載入...
Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study
This study evaluated 12‐week retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C virus (HCV) infection who did not achieve sustained virologic response after previous treatment with a sofosbuvir‐ and velpatasvir‐containing regimen. All 31 patients maintained a s...
Na minha lista:
| 發表在: | J Viral Hepat |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849811/ https://ncbi.nlm.nih.gov/pubmed/30663168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.13067 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|